AU741946B2 - Substituted benzimidazole antiviral agents - Google Patents

Substituted benzimidazole antiviral agents Download PDF

Info

Publication number
AU741946B2
AU741946B2 AU50809/99A AU5080999A AU741946B2 AU 741946 B2 AU741946 B2 AU 741946B2 AU 50809/99 A AU50809/99 A AU 50809/99A AU 5080999 A AU5080999 A AU 5080999A AU 741946 B2 AU741946 B2 AU 741946B2
Authority
AU
Australia
Prior art keywords
alkyl
ylmethyl
benzimidazol
compound
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU50809/99A
Other languages
English (en)
Other versions
AU5080999A (en
Inventor
Rita Lee Civiello
Kathleen F. Kadow
Mark R. Krystal
Nicholas A. Meanwell
Kuo-Long Yu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of AU5080999A publication Critical patent/AU5080999A/en
Application granted granted Critical
Publication of AU741946B2 publication Critical patent/AU741946B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AU50809/99A 1998-07-20 1999-07-20 Substituted benzimidazole antiviral agents Ceased AU741946B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9338798P 1998-07-20 1998-07-20
US60/093387 1998-07-20
PCT/US1999/012398 WO2000004900A1 (en) 1998-07-20 1999-07-20 Substituted benzimidazole antiviral agents

Publications (2)

Publication Number Publication Date
AU5080999A AU5080999A (en) 2000-02-14
AU741946B2 true AU741946B2 (en) 2001-12-13

Family

ID=22238648

Family Applications (1)

Application Number Title Priority Date Filing Date
AU50809/99A Ceased AU741946B2 (en) 1998-07-20 1999-07-20 Substituted benzimidazole antiviral agents

Country Status (6)

Country Link
US (2) US6908936B2 (US06894165-20050517-C00155.png)
EP (1) EP1098644A1 (US06894165-20050517-C00155.png)
JP (1) JP2002521334A (US06894165-20050517-C00155.png)
AU (1) AU741946B2 (US06894165-20050517-C00155.png)
CA (1) CA2338147A1 (US06894165-20050517-C00155.png)
WO (1) WO2000004900A1 (US06894165-20050517-C00155.png)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE04592B1 (et) 1999-06-28 2006-02-15 Janssen Pharmaceutica N.V. Respiratoorse süntsütiaalviiruse replikatsiooni inhibiitorid, nende valmistamismeetod, kasutamine ja vaheühendid, farmatseutiline kompositsioon ja selle valmistamismeetod ning produkt
ATE457177T1 (de) * 2000-05-03 2010-02-15 Medimmune Llc Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe
US6489338B2 (en) * 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
US6506738B1 (en) 2000-09-27 2003-01-14 Bristol-Myers Squibb Company Benzimidazolone antiviral agents
US6774134B2 (en) 2000-12-20 2004-08-10 Bristol-Myers Squibb Company Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
US7030150B2 (en) * 2001-05-11 2006-04-18 Trimeris, Inc. Benzimidazole compounds and antiviral uses thereof
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents
CA2494485A1 (en) * 2002-07-25 2004-02-05 Medimmune, Inc. Methods of treating and preventing rsv, hmpv, and piv using anti-rsv, anti-hmpv, and anti-piv antibodies
US7157471B2 (en) * 2003-08-25 2007-01-02 Boehringer Ingelheim International Gmbh Haloalkyl- and piperidine-substituted benzimidazole-derivatives
WO2005042530A1 (en) 2003-10-30 2005-05-12 Boehringer Ingelheim (Canada) Ltd. Rsv polymerase inhibitors
GB0406280D0 (en) * 2004-03-19 2004-04-21 Arrow Therapeutics Ltd Chemical compounds
GB0501964D0 (en) * 2005-01-31 2005-03-09 Arrow Therapeutics Ltd Chemical compounds
JP4980358B2 (ja) 2005-09-19 2012-07-18 アロー セラピューティクス リミテッド C型肝炎感染症を治療するためのベンゾジアゼピン誘導体
GB0520475D0 (en) * 2005-10-07 2005-11-16 Arrow Therapeutics Ltd Chemical compounds
US20100158863A1 (en) * 2006-01-11 2010-06-24 Arrow Therapeutics Limited Triazoloanilinopyrimidine derivatives for use as antiviral agents
KR101585584B1 (ko) * 2007-08-27 2016-01-14 키네타 포 엘엘씨 아레나바이러스 감염을 치료하기 위한 항바이러스 약물
WO2009062874A2 (en) * 2007-11-15 2009-05-22 F. Hoffmann-La Roche Ag Benzimidazole derivatives and their use as fxr agonists
US9850251B2 (en) 2013-12-10 2017-12-26 Shandong Danhong Pharmaceutical Co., Ltd. Imidazole derivative used as antiviral agent and use therof in preparation of medicament
ES2821649T3 (es) 2015-06-08 2021-04-27 Shangdong Danhong Pharmaceutical Co Ltd Método para preparar derivados de imidazol e intermedios de los mismos y formas cristalinas
CN105820156A (zh) * 2016-04-21 2016-08-03 广东工业大学 苯并三氮唑基苯并咪唑啉及其制备方法和应用
GB201711704D0 (en) * 2017-07-20 2017-09-06 Reviral Ltd Pharmaceutical compounds

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3394141A (en) 1965-11-12 1968-07-23 Fabio Sparatore Z-benzyaminobenzimidazoles
US4324794A (en) * 1980-08-26 1982-04-13 Research Triangle Institute Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds
DK154078C (da) 1981-02-06 1989-05-22 Ucb Sa Analogifremgangsmaade til fremstilling af 2-(2-(4-(diphenyl-methyl)-1-piperazinyl)ethoxy)-acetamider eller syreadditionssalte heraf
US5066656A (en) * 1989-11-01 1991-11-19 Janssen Pharmaceutica N.V. Pharmacologically active (6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)- and (5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl) substituted 1H-benzotriazole derivatives
US5256668A (en) 1993-03-17 1993-10-26 American Home Products Corporation Aminopyrimidine derivatives as antiviral agents for respiratory syncytial virus
BR9700939A (pt) 1996-02-13 1998-09-01 American Cyanamid Co Compostos aniônicos contendo traiazina úteis como agentes antivirais
US6919331B2 (en) * 2001-12-10 2005-07-19 Bristol-Myers Squibb Company Substituted 2-methyl-benzimidazole respiratory syncytial virus antiviral agents

Also Published As

Publication number Publication date
JP2002521334A (ja) 2002-07-16
US7030140B2 (en) 2006-04-18
WO2000004900A1 (en) 2000-02-03
EP1098644A1 (en) 2001-05-16
US20050038085A1 (en) 2005-02-17
US20030139450A1 (en) 2003-07-24
CA2338147A1 (en) 2000-02-03
AU5080999A (en) 2000-02-14
US6908936B2 (en) 2005-06-21

Similar Documents

Publication Publication Date Title
AU741946B2 (en) Substituted benzimidazole antiviral agents
US6844342B2 (en) Heterocyclic substituted 2-methyl-benzimidazole antiviral agents
US6506738B1 (en) Benzimidazolone antiviral agents
EP0596406B1 (en) Imidazo (1,2-a) Pyridines as bradykinin antagonists
US5922711A (en) 8-substituted quinazolines, quinoxalines and benzopyridazines
KR101346823B1 (ko) 헤테로시클릭 화합물
AU715175B2 (en) Selective B3 adrenergic agonists
JP2009143904A (ja) ベンズアミド誘導体
NZ523566A (en) Imidazopyridine and imidazopyrimidine antiviral agents
KR100967406B1 (ko) 호흡기 세포융합 바이러스 복제의 저해제인 벤지미다졸을함유하는 몰포리닐
SK16972002A3 (sk) Beta-karbolínové deriváty použiteľné ako inhibítory fosfodiesterázy
CZ371998A3 (cs) Benzofuranové karboxamidy a jejich terapeutické použití
CZ20023945A3 (cs) Substituované pyrrolopyridinové deriváty pro použití jako inhibitory fosfodiesterázy
CA3047002A1 (en) Compounds useful as inhibitors of indoleamine 2,3-dioxygenase and/or tryptophan dioxygenase
US5750699A (en) Method of preparing certain 3-halo-imidazopyridines
US20170166563A1 (en) 2-amino-benzimidazole derivatives and their use as 5-lipoxygenase and/or prostaglandin e synthase inhibitors
AU2006260969A1 (en) 1- ( 2-amino-3- (substituted alkyl)-3H-benzimidazolylmethyl) -3-substituted-1,3-dihydro-benzoimidazol-2-ones with activity on respiratory syncytial virus
CA2192202A1 (en) Substituted arylalkylthioalkylthiopyridines for use in the control of helicobacter bacteria
ES2225884T3 (es) Nuevos derivados naftiridina.
WO2000034277A1 (fr) Composes de sulfamide et utilisations de ces derniers en tant que medicaments
RU2369606C2 (ru) Производные 5- или 6-замещенных бензимидазолов в качестве ингибиторов репликации респираторного синцитиального вируса
JPH10291988A (ja) 複素環式化合物
US5624948A (en) 1-(2-benzimidazolyl)-1,5-diazacyclooctane compounds
ZA200210104B (en) Imidazopyridine and imidazopyrimidine antiviral agents.

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)